Phase IIa proof-of-principle study for the induction treatment of autoimmune hepatitis using infliximabAIH-MAB Phase IIa proof-of-principle study for the induction treatment of autoimmune hepatitis using inflixi ...
Phase IIa proof-of-principle study for the induction treatment of autoimmune hepatitis using infliximabAIH-MAB Phase IIa proof-of-principle study for the induction treatment of autoimmune hepatitis using inflixi ...
Autoimmune Hepatitis (AIH); rare inflammatory liver disease associated with elevated transaminases, elevated Immunoglobulin G, the presence of autoantibodies and interface hepatitis in liver histology. Untreated, AIH progresses to liver fibrosis and cirrhosis with its complications. Historical placebo-controlled studies could show a mortality of around 70% in the placebo-treated group.;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Autoimmune Hepatitis (AIH); rare inflammatory liver disease associated with elevated transaminases, ...